These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8587428)

  • 1. The endothelin receptor antagonist SB 217242 reduces cerebral focal ischemic brain injury.
    Barone FC; White RF; Elliott JD; Feuerstein GZ; Ohlstein EH
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S404-7. PubMed ID: 8587428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats.
    Zhang Y; Belayev L; Zhao W; Irving EA; Busto R; Ginsberg MD
    Brain Res; 2005 May; 1045(1-2):150-6. PubMed ID: 15910773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
    Ohlstein EH; Nambi P; Lago A; Hay DW; Beck G; Fong KL; Eddy EP; Smith P; Ellens H; Elliott JD
    J Pharmacol Exp Ther; 1996 Feb; 276(2):609-15. PubMed ID: 8632328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats.
    Schäbitz WR; Schwab S; Spranger M; Hacke W
    J Cereb Blood Flow Metab; 1997 May; 17(5):500-6. PubMed ID: 9183287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
    Slivka AP; Murphy EJ
    Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.
    Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
    Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats.
    Briyal S; Gulati K; Gulati A
    Brain Res; 2012 Jan; 1427():23-34. PubMed ID: 22055454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
    Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide scavenger carboxy-PTIO reduces infarct volume following permanent focal ischemia.
    Fang SY; Tseng CC; Yang YL; Lee EJ; Chen HY; Bhardwaj A; Chen TY
    Acta Anaesthesiol Taiwan; 2006 Sep; 44(3):141-6. PubMed ID: 17037001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia.
    Patel TR; Galbraith S; Graham DI; Hallak H; Doherty AM; McCulloch J
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):950-8. PubMed ID: 8784239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
    Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC
    Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats.
    Lämmer A; Günther A; Beck A; Krügel U; Kittner H; Schneider D; Illes P; Franke H
    Eur J Neurosci; 2006 May; 23(10):2824-8. PubMed ID: 16817887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.
    Sayeed I; Guo Q; Hoffman SW; Stein DG
    Ann Emerg Med; 2006 Apr; 47(4):381-9. PubMed ID: 16546625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats.
    Kläsner B; Lumenta DB; Pruneau D; Zausinger S; Plesnila N
    Neurochem Int; 2006 Oct; 49(5):442-7. PubMed ID: 16624448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia.
    Cregan EF; Peeling J; Corbett D; Buchan AM; Saunders J; Auer RN; Gao M; Mccarthy DJ; Eisman MS; Campbell TM; Murray RJ; Stagnitto ML; Palmer GC
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1412-24. PubMed ID: 9400017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-VEGF receptor antagonist (VGA1155) reduces infarction in rat permanent focal brain ischemia.
    Chiba Y; Sasayama T; Miyake S; Koyama J; Kondoh T; Hosoda K; Kohmura E
    Kobe J Med Sci; 2008 Jul; 54(2):E136-46. PubMed ID: 18772615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats.
    Nagayama M; Zhang F; Iadecola C
    J Cereb Blood Flow Metab; 1998 Oct; 18(10):1107-13. PubMed ID: 9778187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia.
    Günther A; Küppers-Tiedt L; Schneider PM; Kunert I; Berrouschot J; Schneider D; Rossner S
    Eur J Neurosci; 2005 Jun; 21(11):3189-94. PubMed ID: 15978027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.